PMD Device Solutions AB (OSTO:PMDS) LT-Debt-to-Total-Asset : 0.01 (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is PMD Device Solutions AB LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. PMD Device Solutions AB's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.01.

PMD Device Solutions AB's long-term debt to total assets ratio declined from Sep. 2023 (0.15) to Sep. 2024 (0.01). It may suggest that PMD Device Solutions AB is progressively becoming less dependent on debt to grow their business.

PMD Device Solutions AB LT-Debt-to-Total-Asset Historical Data

The historical data trend for PMD Device Solutions AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PMD Device Solutions AB LT-Debt-to-Total-Asset Chart

PMD Device Solutions AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.03

0.02

0.03

0.57

PMD Device Solutions AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.15	0.57	0.04	0.01	0.01

PMD Device Solutions AB LT-Debt-to-Total-Asset Calculation

PMD Device Solutions AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	22.466	/	39.479
	=

PMD Device Solutions AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0.889	/	118.972
	=	0.01

PMD Device Solutions AB (OSTO:PMDS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

PMD Device Solutions AB LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of PMD Device Solutions AB's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

PMD Device Solutions AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PMD Device Solutions AB (OSTO:PMDS) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Eversheds Sutherland Advokatbyra AB, Box 14055, Stockholm, SWE, 104 40

Website

https://www.pmd-solutions.com

PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.

PMD Device Solutions AB Headlines

No Headlines